scispace - formally typeset
Open AccessJournal ArticleDOI

Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis.

Reads0
Chats0
TLDR
It is shown that colorectal cancer (CRC) derived exosomal miR-25-3p promotes vascular leakiness and angiogenesis, CRC metastasis, and is upregulated in CRC pateints with metastasis.
Abstract
Cancer-derived exosomes are considered a major driver of cancer-induced pre-metastatic niche formation at foreign sites, but the mechanisms remain unclear. Here, we show that miR-25-3p, a metastasis-promoting miRNA of colorectal cancer (CRC), can be transferred from CRC cells to endothelial cells via exosomes. Exosomal miR-25-3p regulates the expression of VEGFR2, ZO-1, occludin and Claudin5 in endothelial cells by targeting KLF2 and KLF4, consequently promotes vascular permeability and angiogenesis. In addition, exosomal miR-25-3p from CRC cells dramatically induces vascular leakiness and enhances CRC metastasis in liver and lung of mice. Moreover, the expression level of miR-25-3p from circulating exosomes is significantly higher in CRC patients with metastasis than those without metastasis. Our work suggests that exosomal miR-25-3p is involved in pre-metastatic niche formation and may be used as a blood-based biomarker for CRC metastasis. The mechanisms underlying pre-metastatic niche formation by cancer derived exosomes is unclear. Here they show that colorectal cancer (CRC) derived exosomal miR-25-3p promotes vascular leakiness and angiogenesis, CRC metastasis, and is upregulated in CRC pateints with metastasis, and suggest miR-25-3p as a biomarker for CRC metastasis.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance

TL;DR: Understanding exosome biogenesis, their contents and the molecular mechanisms and signaling pathways that are responsible for metastasis and drug-resistance mediated by TDEs may help to devise novel therapeutic approaches for cancer progression particularly to overcome therapy-res resistance and preventing metastasis as major factors of cancer mortality.
Journal ArticleDOI

Cytotoxic CD8 + T cells in cancer and cancer immunotherapy

TL;DR: Advances in research on the most prominent immune effectors in cancer and cancer immunotherapy, cytotoxic T cells, are summarized and possible implications for future cancer treatment are discussed.
Journal ArticleDOI

Application of exosomes as liquid biopsy in clinical diagnosis.

TL;DR: This work investigates publication frequencies on exosomes over the past 10 years, and reviews recent clinical studies on liquid biopsy of exosome in the fields of oncology, pregnancy disorders, cardiovascular diseases, and organ transplantation.
Journal ArticleDOI

Transition metal-based bimetallic MOFs and MOF-derived catalysts for electrochemical oxygen evolution reaction

TL;DR: The transition metal-based bimetallic MOFs (TMB MOFs) with two different metal ions possess specific synergistic effects, which could exhibit OER performance and stability superior to those of the corresponding monometallic MOF for water oxidation.
Journal ArticleDOI

Effects of exosomes on pre-metastatic niche formation in tumors

TL;DR: The effects of exosomes on pre-metastatic niches from various perspectives are analyzed, including inflammation, immune response, angiogenesis, organotropism, matrix remodeling and biomarker expression.
References
More filters
Journal ArticleDOI

Tumour exosome integrins determine organotropic metastasis

TL;DR: It is demonstrated that exosomes from mouse and human lung-, liver- and brain-tropic tumour cells fuse preferentially with resident cells at their predicted destination, namely lung fibroblasts and epithelial cells, liver Kupffer cells and brain endothelial cells.
Related Papers (5)

Tumour exosome integrins determine organotropic metastasis